PRESS RELEASE published on 08/10/2023 at 07:45, 2 years 5 months ago Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
PRESS RELEASE published on 07/21/2023 at 15:21, 2 years 6 months ago EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
PRESS RELEASE published on 06/08/2023 at 11:31, 2 years 7 months ago Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
PRESS RELEASE published on 06/07/2023 at 17:18, 2 years 7 months ago ckert & Ziegler: Annual General Meeting Approves Dividend of EUR 0.50 per Share. Reorganization of the Executive Board, Supervisory Board and Group Executive Committee.
PRESS RELEASE published on 05/30/2023 at 13:00, 2 years 8 months ago Eckert & Ziegler to Host First Radionuclide Theranostics Forum in Boston, MA
PRESS RELEASE published on 05/15/2023 at 09:27, 2 years 8 months ago Reorganization in the Executive Board of Eckert & Ziegler
PRESS RELEASE published on 05/11/2023 at 07:45, 2 years 8 months ago Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
PRESS RELEASE published on 05/08/2023 at 11:15, 2 years 8 months ago Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
PRESS RELEASE published on 04/25/2023 at 17:59, 2 years 9 months ago EQS-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance
PRESS RELEASE published on 04/20/2023 at 10:00, 2 years 9 months ago Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177
Published on 02/06/2026 at 08:00, 2 hours 30 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 00:57, 9 hours 33 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 10 hours 30 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 11 hours 15 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 11 hours 30 minutes ago Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/06/2026 at 09:40, 50 minutes ago Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year
Published on 02/06/2026 at 09:00, 1 hour 30 minutes ago Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 02/06/2026 at 09:00, 1 hour 30 minutes ago Original-Research: tonies SE (von NuWays AG): BUY
Published on 02/05/2026 at 18:06, 16 hours 24 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 16 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
